Clinical pharmacology study of K-237 in healthy adult volunteers

Kowa Company, Ltd.0 个研究点目标入组 12 人开始时间: 2021年10月26日最近更新: 2023年9月8日

试验速览

暂无简介。

•(1) Subject is a healthy adult volunteer.
•(2) Subject is between the ages of 20 and 40 years at the time of signing informed consent.
•(3) Subject has a body mass index of 17.6 to 26.4 kg/m2 at Screening.

•(1) Subject has a supine blood pressure after resting for at least 5 minutes that is lower than 90 mmHg systolic or higher than 140 mmHg systolic, and lower than 40 mmHg diastolic or higher than 90 mmHg diastolic at Screening.
•(2) Subject has used a drug (including over-the-counter drug) within 14 days before the administration of the study drug or a supplement within 4 weeks before the administration of the study drug, or those who need to use it during the study period.
•(3) Subject has a current malabsorption, and those who had an operation on the gastrointestinal tract that may affect absorption (excluding appendectomy and treatment for hernia).

Adverse events and adverse drug reactions

未报告次要终点

发起方